Cystic fibrosis, a genetic disorder that causes severe damage to the lungs and digestive system, is another target for mRNA technology. Scientists are exploring ways to use mRNA to deliver correct ...

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain s GSK and Germany s CureVac $740 million ...